| Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary E Herédi, F Rencz, O Balogh, L Gulácsi, K Herszényi, P Holló, H Jókai, ... The European Journal of Health Economics 15, 111-119, 2014 | 97 | 2014 |
| Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: results of a pilot study H Jókai, J Szakonyi, O Kontár, M Marschalkó, K Szalai, S Kárpáti, P Holló Journal of the American Academy of Dermatology 69 (4), 523-529, 2013 | 93 | 2013 |
| A detailed analysis of ‘not relevant’responses on the DLQI in psoriasis: potential biases in treatment decisions F Rencz, AK Poór, M Péntek, P Holló, S Kárpáti, L Gulácsi, A Szegedi, ... Journal of the European Academy of Dermatology and Venereology 32 (5), 783-790, 2018 | 67 | 2018 |
| Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T‐cell‐mediated skin diseases M Ferran, ER Romeu, C Rincón, M Sagristà, AM Giménez Arnau, ... Experimental Dermatology 22 (7), 439-442, 2013 | 56 | 2013 |
| Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres O Balogh, V Brodszky, L Gulácsi, E Herédi, K Herszényi, H Jókai, ... The European Journal of Health Economics 15, 101-109, 2014 | 50 | 2014 |
| Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients M Marschalkó, N Erős, O Kontár, B Hidvégi, J Telek, J Hársing, H Jókai, ... Journal of the European Academy of Dermatology and Venereology 29 (5), 964-972, 2015 | 45 | 2015 |
| Successful treatment of lichen planus with adalimumab. P Holló, J Szakonyi, D Kiss, H Jokai, A Horváth, S Kárpáti Acta dermato-venereologica 92 (4), 2012 | 43 | 2012 |
| Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity F Rencz, P Holló, S Kárpáti, M Péntek, É Remenyik, A Szegedi, O Balogh, ... Journal of the European Academy of Dermatology and Venereology 29 (7), 1398-1405, 2015 | 31 | 2015 |
| Disease burden of psoriasis associated with psoriatic arthritis in Hungary F Rencz, V Brodszky, M Péntek, O Balogh, É Remenyik, A Szegedi, ... Orvosi Hetilap 155 (48), 1913-1921, 2014 | 25 | 2014 |
| Cutaneous lymphocyte‐associated antigen as a novel predictive marker of TNF‐alpha inhibitor biological therapy in psoriasis H Jókai, J Szakonyi, O Kontár, G Barna, D Inotai, S Kárpáti, P Holló Experimental dermatology 22 (3), 221-223, 2013 | 15 | 2013 |
| Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice K Herszényi, H Jókai, F Rencz, V Brodszky, E Nagy, P Holló Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …, 2019 | 10 | 2019 |
| Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC) P Holló, H Jókai, J Hársing, G Soós, S Kárpáti, K Németh Journal of the American Academy of Dermatology 75 (1), 212-213, 2016 | 10 | 2016 |
| Tissue-specific homing of immune cells in malignant skin tumors H Jókai, M Marschalkó, J Csomor, J Szakonyi, O Kontár, G Barna, ... Pathology & Oncology Research 18, 749-759, 2012 | 10 | 2012 |
| Genitourethral infections caused by D–K serotypes of Chlamydia trachomatis P Holló, H Jókai, K Herszényi, S Kárpáti Orvosi Hetilap 156 (1), 19-23, 2015 | 2 | 2015 |
| Arthritis psoriaticával társuló középsúlyos és súlyos psoriasis betegségterhe Magyarországon F Rencz, V Brodszky, M Péntek, O Balogh, E Remenyik, A Szegedi, ... | 1 | 2014 |
| Kis molekulájú inhibitorok–új távlati lehetőségek a hidradenitisz szuppurativa (HS) kezelésében K Németh, H Jókai Bőrgyógyászati és Venerológiai Szemle 100 (3), 131-142, 2024 | | 2024 |
| Burden of disease among psoriatic patients. PÉ Anna, K Eszter, H Krisztina, J Hajnalka, H Péter | | 2020 |
| 317 Anti-drug antibody formation against biological agents in psoriasis K Herszényi, H Jókai, N Wikonkál, F Rencz, V Brodszky, S Kárpáti, ... Journal of Investigative Dermatology 136 (9), S215, 2016 | | 2016 |
| Potential role of infections behind inefficacy of anti-TNF-alpha treatment of psoriasis K Herszenyi, D Papp, K Polgar, H Jokai, N Wikonkal, D Inotai, A Tordai, ... JOURNAL OF INVESTIGATIVE DERMATOLOGY 135, S41-S41, 2015 | | 2015 |
| The role of predictive markers in TNF-α inhibitor treatment of psoriasis. H Jókai, P Holló | | 2015 |
